Search 2.0 and Keywords: Less TMI, More “There It Is”

Teams across pharmaceutical and biopharma organizations do not usually have a “not enough information” problem.

They have a TMI problem.

Too many posts. Too many conference updates. Too many documents, notes, companies, drugs, acronyms, synonyms, and scientific terms that all seem to point to the same thing — but not always in the same words.

The insight is probably already in inVision.

The real question is: can you find it when you need it?

That is where Search 2.0 and Keywords come together.

Search 2.0 expands what users can search across. Keywords add structure behind the scenes, so important topics, companies, products, mechanisms, diseases, and conference themes can be connected to the different ways people actually refer to them.

The result is a search experience that feels less like hunting through everything and more like getting to the right intelligence faster.

When You Search “J&J,” You Mean More Than Three Characters

Imagine an analyst trying to understand recent activity around Johnson & Johnson.

In the moment, they may not want to build the perfect search query. They may simply type J&J or JNJ because that is how people talk about the company every day.

But relevant intelligence may not always say “J&J.” It may say Johnson & Johnson. It may reference Janssen. It may appear in a conference post, a company mention, a document, or a related project update.

With Keywords and synonyms, inVision can connect those variations so the user is not forced to search every version manually.

That saves time, but it also reduces the chance of missing something important just because a record used a different name.

When “IL17” Shows Up Five Different Ways

Scientific language is precise, but it is not always consistent.

A user looking for IL17 may also need results that mention IL 17, IL-17, or Interleukin 17. Those are all meaningful variations, and in a real research workflow, they should not feel like separate searches.

This is where Keywords become especially useful.

Teams can define keywords and synonyms, and inVision can index content against them. Users then benefit automatically when they search.

So someone researching a mechanism, preparing for a meeting, or reviewing the competitive landscape does not have to stop and think, “Did I search the hyphenated version too?”

Search becomes less about remembering every possible spelling and more about finding the concept.

When You’re Preparing for DDW 2027

Now picture someone preparing for DDW 2027.

They are not just asking, “What do we have on ctDNA?”

They are asking something more useful:

“What happened at DDW 2024, 2025 and 2026 that might help me prepare for what is coming next?”

With Search 2.0, the user can scope the search to those three DDW meetings. A ctDNA search that returns 130 results across every conference narrows to 14 posts from DDW alone.

That makes it easier to spot patterns.

Was a topic quiet in 2024 but more visible in 2026?

Did a competitor start appearing more often?

Did a mechanism, asset, or theme move from background noise to something worth watching?

That is the difference between searching content and preparing with context.

Please register below to access the full content

Register / Sign in

Access your saved articles, exclusive insights, and personalized recommendations.

Your personalized
learning experience awaits.

Gain full access to exclusive resources, webinars, and insights designed to help you grow and stay ahead.

Stay informed. Stay connected. Stay ahead.

Doug Foster, COO of inThought Labs, drives inVision’s growth with AI/ML innovation. MIT graduate with experience in startups, consulting, and global learning leadership at InterSystems and Boston Scientific.

Related Resources

From Abstract Overload to Insight: A Practical AI Workshop for MSLs A 30–45 minute interactive

At most scientific congresses, the real work doesn’t end when the sessions are over. It

Did you know that inVision can search Veeva to help you add and manage KOL

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.